Lauren Santye, Assistant Editor

Lower concentrations of serum zinc can cause difficulties during treatment of patients with HIV.

Top news of the day from across the health care landscape.

Oregon woman infected with HCV from a blood transfusion was at death’s door until she was cured by Harvoni.

Research may lead to new drugs that boost the immune response to HIV.

Breakthrough Therapy Designation nivolumab (Opdivo) granted for previously treated recurrent or metastatic squamous cell carcinoma of the head and neck (SCCHN) after platinum based therapy.

Novel drug delivers enzyme replacement therapies directly to the brain.

Breakthrough Therapy Designation nivolumab (Opdivo) granted for previously treated recurrent or metastatic squamous cell carcinoma of the head and neck (SCCHN) after platinum based therapy.

Top news of the day from across the health care landscape.

Program seeks to help patients overcome fears, such as others learning about their HIV positive status.

The interests of payors, physicians, and patients must be addressed for biosimilars to offer cost savings.

Study highlights importance of a healthy lifestyle in patients with diabetes.

Researchers explore why ocular and facial muscles are spared in patients with Duchenne muscular dystrophy.

Rapid plasma genotyping technique allow for more rapid test results in non-small cell lung cancer.

Abaloparatide-SC found to boost bone mineral density in osteoporosis.

Mevalonate pathway associated with cell-signaling protein that promotes breast cancer development.

Top news of the day from across the health care landscape.

Blue-green algae discovered in Panama carries potent anti-cancer activity.

United States Preventive Services Task Force states screening for chronic obstructive pulmonary disease not be performed without symptoms of the disease.

Gastrointestinal stromal tumors result in higher mortality than originally estimated.

TZD-based medicines effectively improve glucose uptake.

Medi-551 antibody targets the protein CD19 found on the surface of multiple myeloma stem cells.

Top news of the day from across the health care landscape.

Ocrelizumab shows potential treating both relapsing and primary progressive forms of multiple sclerosis.

Ocrelizumab shows potential treating both relapsing and primary progressive forms of multiple sclerosis.

Chronic pain and hormone replacement among the most frequently used compounded medications.

Researchers explore vaccine to produce simultaneous immune response against hepatitis C and HIV.

Engineered immunogens incite the immune system to produce antibodies that show promise for an HIV vaccine.

Advanced T cell receptor sequencing may predict efficacy of immunotherapy in brain cancer treatment.

Zinbryta found to reduce cells that contribute to neurological injury caused by multiple sclerosis.

Top news of the day from across the health care landscape.